CombiMatrix Company
CombiMatrix develops proprietary technologies, products and services for drug development, genetic analysis, molecular diagnostics and more.
%20.jpg)
Estimated Revenue:
$10M to $50M
Technology:
Cancer
Industry:
PharmTech
Investor Type:
N/A
Funding Status:
M&A
Investment Stage:
N/A
Headquarters:
Irvine, California, United States
Number Of Exists:
N/A
Founded Date:
1995
Employee Number:
51-100